Cartesian Therapeutics's total assets for Q1 2026 were $288.39M, a decrease of -2.71% from the previous quarter. RNAC total liabilities were $436.51M for the fiscal quarter, a 3.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.